Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Erika M Kwon

Showing results (21-30 of 41) with videos related to

Pageof 5
Sort By:
Blood|August 13, 2014
Targeted correction of RUNX1 mutation in FPD patient-specific induced pluripotent stem cells rescues megakaryopoietic defectsJon P Connelly, Erika M Kwon, Yongxing Gao, et al.
The Prostate|December 6, 2008
Clinical utility of five genetic variants for predicting prostate cancer risk and mortalityClaudia A Salinas, Joseph S Koopmeiners, Erika M Kwon, et al.
Blood|October 12, 2017
<i>Chd7</i> deficiency delays leukemogenesis in mice induced by <i>Cbfb-MYH11</i>Tao Zhen, Erika M Kwon, Ling Zhao, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 27, 2011
Expression of SLCO transport genes in castration-resistant prostate cancer and impact of genetic variation in SLCO1B3 and SLCO2B1 on prostate cancer outcomesJonathan L Wright, Erika M Kwon, Elaine A Ostrander, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 7, 2011
Genome-wide association study identifies a genetic variant associated with risk for more aggressive prostate cancerLiesel M FitzGerald, Erika M Kwon, Matthew P Conomos, et al.
Plos One|July 31, 2012
ADP ribosylation by PARP-1 suppresses HOXB7 transcriptional activityXinyan Wu, Stephan Ellmann, Ethel Rubin, et al.
Cancer Research|November 26, 2009
Testing the circadian gene hypothesis in prostate cancer: a population-based case-control studyYong Zhu, Richard G Stevens, Aaron E Hoffman, et al.
Human Mutation|August 14, 2012
Investigation of the relationship between prostate cancer and MSMB and NCOA4 genetic variants and protein expressionLiesel M FitzGerald, Xiaotun Zhang, Suzanne Kolb, et al.
The Prostate|March 21, 2007
Suggestive genetic linkage to chromosome 11p11.2-q12.2 in hereditary prostate cancer families with primary kidney cancerBo Johanneson, Kerry Deutsch, Laura McIntosh, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 8, 2017
iPSCs and fibroblast subclones from the same fibroblast population contain comparable levels of sequence variationsErika M Kwon, John P Connelly, Nancy F Hansen, et al.
Pageof 5

Showing results (21-30 of 41) with videos related to

Sort By:
Pageof 5
Blood|August 13, 2014
Targeted correction of RUNX1 mutation in FPD patient-specific induced pluripotent stem cells rescues megakaryopoietic defectsJon P Connelly, Erika M Kwon, Yongxing Gao, et al.
The Prostate|December 6, 2008
Clinical utility of five genetic variants for predicting prostate cancer risk and mortalityClaudia A Salinas, Joseph S Koopmeiners, Erika M Kwon, et al.
Blood|October 12, 2017
<i>Chd7</i> deficiency delays leukemogenesis in mice induced by <i>Cbfb-MYH11</i>Tao Zhen, Erika M Kwon, Ling Zhao, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 27, 2011
Expression of SLCO transport genes in castration-resistant prostate cancer and impact of genetic variation in SLCO1B3 and SLCO2B1 on prostate cancer outcomesJonathan L Wright, Erika M Kwon, Elaine A Ostrander, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 7, 2011
Genome-wide association study identifies a genetic variant associated with risk for more aggressive prostate cancerLiesel M FitzGerald, Erika M Kwon, Matthew P Conomos, et al.
Plos One|July 31, 2012
ADP ribosylation by PARP-1 suppresses HOXB7 transcriptional activityXinyan Wu, Stephan Ellmann, Ethel Rubin, et al.
Cancer Research|November 26, 2009
Testing the circadian gene hypothesis in prostate cancer: a population-based case-control studyYong Zhu, Richard G Stevens, Aaron E Hoffman, et al.
Human Mutation|August 14, 2012
Investigation of the relationship between prostate cancer and MSMB and NCOA4 genetic variants and protein expressionLiesel M FitzGerald, Xiaotun Zhang, Suzanne Kolb, et al.
The Prostate|March 21, 2007
Suggestive genetic linkage to chromosome 11p11.2-q12.2 in hereditary prostate cancer families with primary kidney cancerBo Johanneson, Kerry Deutsch, Laura McIntosh, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 8, 2017
iPSCs and fibroblast subclones from the same fibroblast population contain comparable levels of sequence variationsErika M Kwon, John P Connelly, Nancy F Hansen, et al.
Pageof 5